Financial Metrics Exploration: Understanding Macrogenics Inc (MGNX) Through Ratios

In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The closing price of Macrogenics Inc (NASDAQ: MGNX) was $4.37 for the day, up 6.07% from the previous closing price of $4.12. In other words, the price has increased by $6.07 from its previous closing price. On the day, 6.29 million shares were traded. MGNX stock price reached its highest trading level at $4.38 during the session, while it also had its lowest trading level at $4.04.

Ratios:

Our analysis of MGNX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.61 and its Current Ratio is at 3.63. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.28.

On May 10, 2024, Stifel Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $29 to $7.

BMO Capital Markets Downgraded its Outperform to Market Perform on May 10, 2024, whereas the target price for the stock was revised from $24 to $8.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 04 ’24 when Peters Jeffrey Stuart sold 51,395 shares for $15.55 per share. The transaction valued at 799,148 led to the insider holds 0 shares of the business.

Peters Jeffrey Stuart sold 19,625 shares of MGNX for $421,938 on Mar 06 ’24. The Senior VP and General Counsel now owns 8,895 shares after completing the transaction at $21.50 per share. On Mar 04 ’24, another insider, Risser Eric Blasius, who serves as the Chief Operating Officer of the company, sold 41,159 shares for $19.76 each. As a result, the insider received 813,501 and left with 38,900 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MGNX now has a Market Capitalization of 273708384 and an Enterprise Value of 123483224. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.31 while its Price-to-Book (P/B) ratio in mrq is 2.58. Its current Enterprise Value per Revenue stands at 2.848 whereas that against EBITDA is -0.705.

Stock Price History:

Over the past 52 weeks, MGNX has reached a high of $21.88, while it has fallen to a 52-week low of $3.14. The 50-Day Moving Average of the stock is -53.95%, while the 200-Day Moving Average is calculated to be -57.10%.

Shares Statistics:

MGNX traded an average of 2.42M shares per day over the past three months and 1777200 shares per day over the past ten days. A total of 62.07M shares are outstanding, with a floating share count of 58.46M. Insiders hold about 6.66% of the company’s shares, while institutions hold 104.71% stake in the company. Shares short for MGNX as of 1715731200 were 8888623 with a Short Ratio of 4.09, compared to 1713139200 on 8599115. Therefore, it implies a Short% of Shares Outstanding of 8888623 and a Short% of Float of 17.419999999999998.

Most Popular